DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
FORODESINE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphoid; Lymphoma; Lymphoma, T-Cell, Peripheral; Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell
Purine nucleoside phosphorylase inhibitor
FORODESINE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
6SN82Y9U73
Molecule Type:
Small molecule
Molecular Formula:
C11H15ClN4O4
Molecular Weight:
302.72
AlogP:
-2.02
PSA:
134.26
HBD:
6.0
HBA:
#RotB:
2.0
Source:
[18F]D
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
[18F]D
×
Maximum Phase:
2
First Approval:
None
UNII:
Y1H4D2VKZD
Molecule Type:
Small molecule
Molecular Formula:
C22H27FN4O2
Molecular Weight:
398.48
AlogP:
3.77
PSA:
59.73
HBD:
0.0
HBA:
#RotB:
8.0
Source:
PF-06372865
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-06372865
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RESIQUIMOD
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Basal Cell; Hepatitis B, Chronic; Influenza, Human; Neoplasms; Astrocytoma; Glioblastoma; Keratosis, Actinic; Lymphoma, T-Cell, Cutaneous; Melanoma; Oligodendroglioma
Unknown
RESIQUIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
V3DMU7PVXF
Molecule Type:
Small molecule
Molecular Formula:
C17H22N4O2
Molecular Weight:
314.39
AlogP:
2.47
PSA:
86.19
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BMS-741672
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia
C-C chemokine receptor type 2 antagonist
BMS-741672
×
Maximum Phase:
2
First Approval:
None
UNII:
3UAA36FHF1
Molecule Type:
Small molecule
Molecular Formula:
C24H33F3N6O3S
Molecular Weight:
542.63
AlogP:
2.84
PSA:
107.53
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BROXURIDINE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia; Prostatic Neoplasms, Castration-Resistant
Unknown
BROXURIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
G34N38R2N1
Molecule Type:
Small molecule
Molecular Formula:
C9H11BrN2O5
Molecular Weight:
307.1
AlogP:
-1.06
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
BMS-823778
2
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders
11-beta-hydroxysteroid dehydrogenase 1 inhibitor
BMS-823778
×
Maximum Phase:
2
First Approval:
None
UNII:
8JYO8VTR11
Molecule Type:
Small molecule
Molecular Formula:
C18H19Cl2N3O
Molecular Weight:
364.28
AlogP:
3.69
PSA:
50.42
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SAR425899
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Glucagon receptor agonist
SAR425899
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLORBENAZINE F 18
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLORBENAZINE F 18
×
Maximum Phase:
2
First Approval:
None
UNII:
KM31LBX59H
Molecule Type:
Small molecule
Molecular Formula:
C21H32FNO3
Molecular Weight:
364.49
AlogP:
3.76
PSA:
41.93
HBD:
1.0
HBA:
#RotB:
7.0
Source:
ELIPRODIL
2
Small molecule
Investigational
Unknown
Unknown
Movement Disorders; Parkinson Disease
Unknown
ELIPRODIL
×
Maximum Phase:
2
First Approval:
None
UNII:
YW62A6TW29
Molecule Type:
Small molecule
Molecular Formula:
C20H23ClFNO
Molecular Weight:
347.86
AlogP:
4.47
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DIAZEPINOMICIN
2
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Unknown
DIAZEPINOMICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
YPH994Y0RF
Molecule Type:
Small molecule
Molecular Formula:
C28H34N2O4
Molecular Weight:
462.59
AlogP:
6.93
PSA:
93.03
HBD:
4.0
HBA:
#RotB:
8.0
Source:
TRANILAST
2
Small molecule
Investigational
Unknown
Unknown
Sarcoidosis; Scleredema Adultorum; Arthritis, Rheumatoid; Pterygium
Unknown
TRANILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
HVF50SMY6E
Molecule Type:
Small molecule
Molecular Formula:
C18H17NO5
Molecular Weight:
327.34
AlogP:
3.05
PSA:
84.86
HBD:
2.0
HBA:
#RotB:
6.0
Source:
DISACCHARIDE TRIPEPTIDE GLYCEROL DIPALMITOYL
2
Small molecule
Investigational
Unknown
Unknown
Sarcoma, Ewing
Unknown
DISACCHARIDE TRIPEPTIDE GLYCEROL DIPALMITOYL
×
Maximum Phase:
2
First Approval:
None
UNII:
6PHSP9EORV
Molecule Type:
Small molecule
Molecular Formula:
C65H116N6O21
Molecular Weight:
1317.66
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MT-3995
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Nephropathies; Non-alcoholic Fatty Liver Disease
Mineralocorticoid receptor antagonist
MT-3995
×
Maximum Phase:
2
First Approval:
None
UNII:
832663U2NB
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARFENTANIL
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia
Unknown
CARFENTANIL
×
Maximum Phase:
2
First Approval:
None
UNII:
LA9DTA2L8F
Molecule Type:
Small molecule
Molecular Formula:
C24H30N2O3
Molecular Weight:
394.51
AlogP:
3.68
PSA:
49.85
HBD:
0.0
HBA:
#RotB:
7.0
Source:
ADOMEGLIVANT
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Renal Insufficiency, Chronic; Diabetes Mellitus, Type 2
Glucagon receptor antagonist
ADOMEGLIVANT
×
Maximum Phase:
2
First Approval:
None
UNII:
74Z5ZL2KVG
Molecule Type:
Small molecule
Molecular Formula:
C32H36F3NO4
Molecular Weight:
555.64
AlogP:
7.94
PSA:
75.63
HBD:
2.0
HBA:
#RotB:
10.0
Source:
PAMAPIMOD
2
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
PAMAPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
8S2C9V11K4
Molecule Type:
Small molecule
Molecular Formula:
C19H20F2N4O4
Molecular Weight:
406.39
AlogP:
1.94
PSA:
109.5
HBD:
3.0
HBA:
#RotB:
8.0
Source:
BRECANAVIR
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
HIV-1 protease inhibitor
BRECANAVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
E367I8C7FI
Molecule Type:
Small molecule
Molecular Formula:
C33H41N3O10S2
Molecular Weight:
703.84
AlogP:
3.87
PSA:
154.98
HBD:
2.0
HBA:
#RotB:
14.0
Source:
BMS-833923
2
Small molecule
Investigational
Unknown
Unknown
Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Esophageal Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Stomach Neoplasms; Leukemia
Smoothened homolog antagonist
BMS-833923
×
Maximum Phase:
2
First Approval:
None
UNII:
41J7ZJ239R
Molecule Type:
Small molecule
Molecular Formula:
C30H27N5O
Molecular Weight:
473.58
AlogP:
6.32
PSA:
78.94
HBD:
3.0
HBA:
#RotB:
7.0
Source:
FOSLINANIB
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma; Neoplasms; Carcinoma, Hepatocellular
Unknown
FOSLINANIB
×
Maximum Phase:
2
First Approval:
None
UNII:
2X2DNM7NGX
Molecule Type:
Small molecule
Molecular Formula:
C16H13FNO6P
Molecular Weight:
365.25
AlogP:
2.81
PSA:
108.85
HBD:
3.0
HBA:
#RotB:
4.0
Source:
SUNOBINOP
2
Small molecule
Investigational
Unknown
Unknown
Pain; Sleep Initiation and Maintenance Disorders
Unknown
SUNOBINOP
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C26H33N3O3
Molecular Weight:
435.57
AlogP:
4.62
PSA:
75.43
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BRYOSTATIN 1
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BRYOSTATIN 1
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TONAPOFYLLINE
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Heart Failure; Renal Insufficiency
Adenosine A1 receptor antagonist
TONAPOFYLLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
83VNU4U44T
Molecule Type:
Small molecule
Molecular Formula:
C22H32N4O4
Molecular Weight:
416.52
AlogP:
3.16
PSA:
109.98
HBD:
2.0
HBA:
#RotB:
8.0
Source:
IDOXIFENE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Estrogen receptor modulator
IDOXIFENE
×
Maximum Phase:
2
First Approval:
None
UNII:
456UXE9867
Molecule Type:
Small molecule
Molecular Formula:
C28H30INO
Molecular Weight:
523.46
AlogP:
7.13
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
8.0
Source:
LY2196044
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LY2196044
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAZUVAPAGON
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LAZUVAPAGON
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C27H32N4O3
Molecular Weight:
460.58
AlogP:
3.59
PSA:
87.46
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SIMUROSERTIB
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cell division cycle 7-related protein kinase inhibitor
SIMUROSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
LST350G3XU
Molecule Type:
Small molecule
Molecular Formula:
C17H19N5OS
Molecular Weight:
341.44
AlogP:
2.84
PSA:
77.67
HBD:
2.0
HBA:
#RotB:
2.0
Source:
MESDOPETAM
2
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Unknown
MESDOPETAM
×
Maximum Phase:
2
First Approval:
None
UNII:
HD4QV8GX26
Molecule Type:
Small molecule
Molecular Formula:
C12H18FNO3S
Molecular Weight:
275.35
AlogP:
1.61
PSA:
55.4
HBD:
1.0
HBA:
#RotB:
7.0
Source:
RAZUPROTAFIB
2
Small molecule
Investigational
Unknown
Unknown
Retinal Vein Occlusion
Receptor-type tyrosine-protein phosphatase beta inhibitor
RAZUPROTAFIB
×
Maximum Phase:
2
First Approval:
None
UNII:
0WAX4UT396
Molecule Type:
Small molecule
Molecular Formula:
C26H26N4O6S3
Molecular Weight:
586.72
AlogP:
4.45
PSA:
146.72
HBD:
4.0
HBA:
#RotB:
11.0
Source:
OLOROFIM
2
Small molecule
Investigational
Unknown
Unknown
Aspergillosis; Leukemia, Myeloid, Acute; Liver Diseases; Mycoses
Dihydroorotate dehydrogenase (quinone), mitochondrial inhibitor
OLOROFIM
×
Maximum Phase:
2
First Approval:
None
UNII:
T34SH2H9HI
Molecule Type:
Small molecule
Molecular Formula:
C28H27FN6O2
Molecular Weight:
498.56
AlogP:
4.08
PSA:
83.36
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CARMOTEROL
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
CARMOTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
9810NUL4D1
Molecule Type:
Small molecule
Molecular Formula:
C21H24N2O4
Molecular Weight:
368.43
AlogP:
2.5
PSA:
94.58
HBD:
4.0
HBA:
#RotB:
7.0
Source:
DWP05195
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia, Postherpetic
Vanilloid receptor antagonist
DWP05195
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DELTA 8-TETRAHYDROCANNOBINOL
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
DELTA 8-TETRAHYDROCANNOBINOL
×
Maximum Phase:
2
First Approval:
None
UNII:
B49D0HH807
Molecule Type:
Small molecule
Molecular Formula:
C21H30O2
Molecular Weight:
314.47
AlogP:
5.74
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TARTRATE
2
Small molecule
Investigational
Unknown
Unknown
Dementia
Unknown
TARTRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
4J4Z8788N8
Molecule Type:
Small molecule
Molecular Formula:
C4H6O6
Molecular Weight:
150.09
AlogP:
-2.12
PSA:
115.06
HBD:
4.0
HBA:
#RotB:
3.0
Source:
(-)-EPICATECHIN
2
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary; Muscular Dystrophy, Duchenne
Unknown
(-)-EPICATECHIN
×
Maximum Phase:
2
First Approval:
None
UNII:
34PHS7TU43
Molecule Type:
Small molecule
Molecular Formula:
C15H14O6
Molecular Weight:
290.27
AlogP:
1.55
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
1
2
…
130
131
132
133
134
135
136
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA